Back to Evidence
Primary experimental recordPositive observation

PMC12935919::ACT037542

Myoki

Evidence text

Paper-level observation

Figure 1C caption: 'Quantification of Day 6 myotube morphology, including relative myotube length and relative myotube thickness... *p < 0.05, **p < 0.01, ***p < 0.001 vs. DM group.'
figureConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
Other
Measure
fold_change
Comparator
>
Raw observation
significant increase (p<0.05 to p<0.001) at 50 and 100 μM
Normalized measurement
>0.05
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Mus musculus
Assay method
Not reported by source
Sequence
EAEYEHL
Standardization
ready simple

Source publication

The therapeutic potential of Myoki, a novel peptide in muscle atrophy: mechanisms and applications.

Frontiers in Pharmacology · 2026

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.